SOAT1 and metastatic neoplasm: The 112 cases were separated into two different groups according to ENSAT stage at diagnosis, and we evaluated the impact of SOAT1 protein expression on PFS in the subgroup of patients with metastatic disease at diagnosis (ENSAT 4; n = 22), and on RFS in the subgroup of patients with localized disease at diagnosis who underwent complete surgical resection of the primary tumor (resection status R0 (n = 83)).